Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Beta-3-adrenergic Receptor rs4994 Polymorphism Is a Potential Biomarker for the Development of Nonalcoholic Fatty Liver Disease in Overweight/Obese Individuals.

Sakamoto Y, Oniki K, Kumagae N, Morita K, Otake K, Ogata Y, Saruwatari J.

Dis Markers. 2019 Dec 17;2019:4065327. doi: 10.1155/2019/4065327. eCollection 2019.

2.

Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model.

Maeda H, Minayoshi Y, Ichimizu S, Mizuta Y, Nagasaki T, Matsusaka K, Oshiro S, Oniki K, Saruwatari J, Ishima Y, Watanabe H, Otagiri M, Maruyama T.

Biol Pharm Bull. 2020;43(1):93-101. doi: 10.1248/bpb.b19-00599.

3.

Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions.

Inaba I, Kondo Y, Iwasaki S, Tsuruhashi S, Akaishi A, Morita K, Oniki K, Saruwatari J, Ishitsuka Y, Irie T.

Front Pharmacol. 2019 Aug 8;10:874. doi: 10.3389/fphar.2019.00874. eCollection 2019.

4.

[A Multifaceted Approach regarding the Association of the DsbA-L Gene with the Risk of Obesity-related Diseases Based on Clinical Pharmacogenetics].

Oniki K, Saruwatari J.

Yakugaku Zasshi. 2019;139(1):53-60. doi: 10.1248/yakushi.18-00163-3. Review. Japanese.

5.

Integrated analysis of microRNA and mRNA expression profiles in splenomegaly induced by non-cirrhotic portal hypertension in rats.

Saruwatari J, Dong C, Utsumi T, Tanaka M, McConnell M, Iwakiri Y.

Sci Rep. 2018 Dec 20;8(1):17983. doi: 10.1038/s41598-018-36297-0.

6.

Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.

Oniki K, Watanabe T, Kudo M, Izuka T, Ono T, Matsuda K, Sakamoto Y, Nagaoka K, Imafuku T, Ishima Y, Watanabe H, Maruyama T, Otake K, Ogata Y, Saruwatari J.

CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):384-393. doi: 10.1002/psp4.12292. Epub 2018 Mar 30.

7.

CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina.

Akasaka T, Sueta D, Arima Y, Tabata N, Takashio S, Izumiya Y, Yamamoto E, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Hokimoto S.

Int J Cardiol Heart Vasc. 2017 Apr 12;15:15-20. doi: 10.1016/j.ijcha.2017.03.001. eCollection 2017 Jun.

8.

Predictive factors for effectiveness and safety of enoxaparin for total knee arthroplasty in aged Japanese patients: a retrospective review.

Sonoda A, Kondo Y, Tsuneyoshi Y, Iwashita Y, Nakao S, Ishida K, Oniki K, Saruwatari J, Irie T, Ishitsuka Y.

J Pharm Health Care Sci. 2017 Jan 18;3:6. doi: 10.1186/s40780-017-0075-x. eCollection 2017.

9.

Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction.

Tabata N, Sueta D, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Hokimoto S.

PLoS One. 2016 Nov 10;11(11):e0166240. doi: 10.1371/journal.pone.0166240. eCollection 2016.

10.

Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.

Akasaka T, Sueta D, Arima Y, Tabata N, Takashio S, Izumiya Y, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Matsui K, Hokimoto S.

Am J Physiol Heart Circ Physiol. 2016 Dec 1;311(6):H1409-H1415. doi: 10.1152/ajpheart.00473.2016. Epub 2016 Sep 23.

11.

The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.

Soraoka H, Oniki K, Matsuda K, Ono T, Taharazako K, Uchiyashiki Y, Kamihashi R, Kita A, Takashima A, Nakagawa K, Yasui-Furukori N, Kadowaki D, Miyata K, Saruwatari J.

Biol Pharm Bull. 2016;39(9):1468-74. doi: 10.1248/bpb.b16-00248.

12.

Common variants of HNF1A gene are associated with diabetic retinopathy and poor glycemic control in normal-weight Japanese subjects with type 2 diabetes mellitus.

Morita K, Saruwatari J, Tanaka T, Oniki K, Kajiwara A, Miyazaki H, Yoshida A, Jinnouchi H, Nakagawa K.

J Diabetes Complications. 2017 Feb;31(2):483-488. doi: 10.1016/j.jdiacomp.2016.06.007. Epub 2016 Jun 14.

PMID:
27445006
13.

Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes.

Kajiwara A, Kita A, Saruwatari J, Miyazaki H, Kawata Y, Morita K, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K.

J Diabetes Res. 2016;2016:4626382. doi: 10.1155/2016/4626382. Epub 2016 May 9.

14.

Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis.

Nishimura M, Ueda M, Saruwatari J, Nakashima H, Ogusu N, Aoki A, Tsuchimine S, Matsuda K, Iwashita K, Ono T, Oniki K, Shimoda K, Yasui-Furukori N.

Pharmacogenet Genomics. 2016 Sep;26(9):403-13. doi: 10.1097/FPC.0000000000000228.

PMID:
27187662
15.

Helicobacter Pylori-seropositivity along with genetic and environmental factors predicts clinical outcome after acute coronary syndrome.

Tabata N, Hokimoto S, Akasaka T, Sueta D, Arima Y, Sakamoto K, Yamamoto E, Izumiya Y, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogawa H.

Int J Cardiol. 2016 Jun 1;212:54-6. doi: 10.1016/j.ijcard.2016.03.034. Epub 2016 Mar 16. No abstract available.

PMID:
27019048
16.

Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study.

Oniki K, Kamihashi R, Tomita T, Ishioka M, Yoshimori Y, Osaki N, Tsuchimine S, Sugawara N, Kajiwara A, Morita K, Miyata K, Otake K, Nakagawa K, Ogata Y, Saruwatari J, Yasui-Furukori N.

Psychiatry Res. 2016 May 30;239:190-5. doi: 10.1016/j.psychres.2016.03.025. Epub 2016 Mar 16.

PMID:
27010189
17.

Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.

Akasaka T, Hokimoto S, Sueta D, Tabata N, Sakamoto K, Yamamoto E, Yamamuro M, Tsujita K, Kojima S, Kaikita K, Kajiwara A, Morita K, Oniki K, Saruwatari J, Nakagawa K, Ogata Y, Ogawa H.

Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1494-500. doi: 10.1152/ajpheart.00911.2015. Epub 2016 Mar 18.

18.

The Influence of Phacoemulsification on Surgical Outcomes of Trabeculectomy with Mitomycin-C for Uveitic Glaucoma.

Nishizawa A, Inoue T, Ohira S, Takahashi E, Saruwatari J, Iwao K, Tanihara H.

PLoS One. 2016 Mar 18;11(3):e0151947. doi: 10.1371/journal.pone.0151947. eCollection 2016.

19.

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.

Nakashima H, Oniki K, Nishimura M, Ogusu N, Shimomasuda M, Ono T, Matsuda K, Yasui-Furukori N, Nakagawa K, Ishitsu T, Saruwatari J.

PLoS One. 2015 Oct 20;10(10):e0141266. doi: 10.1371/journal.pone.0141266. eCollection 2015.

20.

Higher risk of sulfonylurea-associated hypoglycemic symptoms in women with type 2 diabetes mellitus.

Kajiwara A, Kita A, Saruwatari J, Oniki K, Morita K, Yamamura M, Murase M, Koda H, Hirota S, Ishizuka T, Nakagawa K.

Clin Drug Investig. 2015 Sep;35(9):593-600. doi: 10.1007/s40261-015-0314-6.

PMID:
26293520

Supplemental Content

Loading ...
Support Center